Cited by 144Food composition and propertiesDiabetes Treatment and ManagementNatural Antidiabetic Agents Studies

Psyllium fiber improves glycemic control proportional to loss of glycemic control: A meta-analysis of data in euglycemic subjects, patients at risk of type 2 diabetes mellitus, and patients being treated for type 2 diabetes mellitus

Open access
Gibb, Roger D, McRorie, Johnson W, Russell, Darrell A, Hasselblad, Vic, D’Alessio, David A·2015·The American Journal of Clinical Nutrition

Abstract

Background A number of health benefits are associated with intake of soluble, viscous, gel-forming fibers, including reduced serum cholesterol and the attenuation of postprandial glucose excursions.Objective We assess the effects of psyllium, which is a soluble, gel-forming, nonfermented fiber supplement, on glycemic control in patients who were being treated for type 2 diabetes mellitus (T2DM) and in patients who were at risk of developing T2DM.Design A comprehensive search was performed of available published literature (Scopus scientific database) and clinical records stored by Procter & Gamble with the use of key search terms to identify clinical studies that assessed the glycemic effects of psyllium in nondiabetic, pre-T2DM, and T2DM patients.Results We identified 35 randomized, controlled, clinical studies that spanned 3 decades and 3 continents. These data were assessed in 8 meta-analyses. In patients with T2DM, multiweek studies (psyllium dosed before meals) showed significant improvement in both the fasting blood glucose (FBG) concentration (-37.0 mg/dL; P < 0.001) and glycated hemoglobin (HbA1c) [-0.97% (-10.6 mmol/mol); P = 0.048]. Glycemic effects were proportional to baseline FBG; no significant glucose lowering was observed in euglycemic subjects, a modest improvement was observed in subjects with pre-T2DM, and the greatest improvement was observed in subjects who were being treated for T2DM.Conclusions These data indicate that psyllium would be an effective addition to a lifestyle-intervention program. The degree of psyllium's glycemic benefit was commensurate with the loss of glycemic control. Because the greatest effect was seen in patients who were being treated for T2DM, additional studies are needed to determine how best to incorporate psyllium into existing prevention and treatment algorithms with concomitant hypoglycemic medications.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3945/ajcn.115.106989

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A meta-analysis restricted to US studies of persons with diabetes not using pharmacologic treatment or using oral antihyperglycemic agents did not show a significant increase in accident risk.

    “A meta-analysis restricted to US studies of persons with DM not using pharmacologic treatment or using oral antihyperglycemic agents did not show a significant increase in risk of accidents.”

    From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1698]

    The meta-analysis methods passage lists glycemic outcomes, and Table 3 includes studies from countries outside the United States. Searches for accidents, accident risk, and pharmacologic treatment found no passage assessing accident risk in the specified treatment groups. The claim therefore cannot be verified from our copy. (LLM, conf=0.78)

    Experimental — accuracy not yet measured
  • Among individual studies in the analysis, sulfonylurea use did not significantly increase accident risk.

    “Among individual studies included in the analysis, use of SU did not significantly increase the risk of accidents.1696–1698”

    From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1698]

    The methods passage describing the eight meta-analyses lists glycemic endpoints, not accidents. A discussion passage addresses hypoglycemia in relation to psyllium but does not report accident risk from sulfonylurea use. Searches for sulfonylureas, accidents, and individual-study accident risk found no passage addressing the claim; page numbers were unavailable in our copy. (LLM, conf=0.76)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. [10]10. Sartor G, Carlstro ¨m S, Scherstén B. Dietary supplementation of fi- bre (Lunelax) as a means to reduce postprandial glucose in di- abetics. Acta Med Scand Suppl 1981;656:51-3.
  2. [14]14. Dastjerdi M, Salehion M, Najafian A, Amini M. A randomized con- trolled study for evaluation of psyllium effects on kinetics of carbo- hydrate absorption. J Res Med Sci 2007;12:125-30.
  3. [23]23. Lu C, Lee W, Wang J. Clinical assessment of the effects of psyllium on weight control and the lipid profile of obese adults. Nutr Sci J 2012;37: 136-46.

Cited by

Sorted by citations

Authors
Gibb, R. D., McRorie, J. W., Russell, D. A., Hasselblad, V., & D’Alessio, D. A.
Affiliations
  • Procter & Gamble (United States) (US)
  • Duke University (US)
Corresponding author
Gibb, Roger D
Venue
The American Journal of Clinical Nutrition
Publisher
Elsevier BV
Published
2015-12
Volume
102
Issue
6
Pages
1604-1614
ISSN
0002-9165 (ISSN-L)
OpenAlex
W2178033703
Cited by
144
References
48
Citations by year
2026: 7 · 2025: 21 · 2024: 19 · 2023: 18 · 2022: 11 · 2021: 15 · 2020: 9 · 2019: 11 · 2018: 12 · 2017: 17 · 2016: 4
FWCI
1.41
Type
journal article
Language
en
Open access
Locations
  • American Journal of Clinical Nutrition (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Food composition and properties
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
Keywords
psyllium, soluble dietary fiber, dietary fiber supplementation, glycemic control, type 2 diabetes, prediabetes, fasting blood glucose, HbA1c, postprandial blood glucose, lifestyle intervention, hypoglycemic medications
MeSH terms
Combined Modality Therapy, Diabetes Mellitus, Type 2, Glycated Hemoglobin, Humans, Hyperglycemia, Hypoglycemia, Prediabetic State, Psyllium, Risk, Randomized Controlled Trials as Topic, Evidence-Based Medicine, Prebiotics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review